Posttransplant Diabetes Mellitus: Cause, Impact, and Treatment Options

Nutrition in Clinical Practice

Volumn 19, Issue 2, 2004, Pages 165-171

  Obayashi, Patricia A C ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; AZATHIOPRINE; BIGUANIDE DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN A; GLIBENCLAMIDE; GLIBENCLAMIDE PLUS METFORMIN; GLIPIZIDE; GLIPIZIDE PLUS METFORMIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; INSULIN LISPRO; MEGLITINIDE; METFORMIN; METFORMIN PLUS ROSIGLITAZONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MIGLITOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; PREDNISONE; RAPAMYCIN; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; TACROLIMUS; THYMOCYTE ANTIBODY; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; ANOREXIA; CASE REPORT; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEHYDRATION; DIABETES MELLITUS; DIABETOGENESIS; DIARRHEA; DIET THERAPY; DRUG FATALITY; ETHNIC GROUP; FAMILY HISTORY; FEMALE; FLATULENCE; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOGLYCEMIA; INCIDENCE; INCREASED APPETITE; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIVER TOXICITY; LONG TERM CARE; MALE; NAUSEA; PATIENT EDUCATION; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR; SIDE EFFECT; SORE THROAT; TASTE DISORDER; THROMBOCYTE AGGREGATION; TRANSPLANTATION; VOMITING; WEIGHT GAIN; WOUND INFECTION;

EID: 1642504909     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426504019002165     Document Type: Review

References (21)

1. Welch CB. Diabetes 2001 Vital Statistics. Alexandria, Virginia: American Diabetes Association; 2001.
2. Funnell M, Hunt C, Kulkarni K, Rubin RR, Yarborough PC. A Core Curriculum for Diabetes Education. 3rd ed. Chicago, Ill: American Association of Diabetes Educators; 1998.
3. Teran JC, McCullough AJ. Nutrition in liver disease. In: Gottschlich MM, Fuhrman MP, Hammond KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support: A Case-Based Core Curriculum. Dubuque, Iowa: Kendall/Hunt Publishing Company; 2000:537-552.
4. Wilkinson AH. Posttransplant diabetes mellitus: serious issue in transplantation. Postgraduate Institute for Medicine, July 2002. A continuing education slide program, Universal Program Number 809-999-02-023-H01.
5. American Diabetes Association: clinical practice recommendations 2003. Diabetes Care. 2003;26(suppl 1):S5-S20.
6. Buse J, Benjamin EM, Calomo J, Riddle MC, Rubin MC, Thompson MJ. Diabetes in African Americans, Latino Americans, and Native Americans. Balance Perspect Diabetes Manage. 2001;2:11-15.
7. Obayashi P, Simos A. Participants in the diabetes transplant and cystic fibrosis program improve blood glucose pre- and postmultiorgan transplantation. UCSF Stanford Research Day, 2002.
8. Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999; 34:1-13.
9. DiCecco SR, Francisco-Ziller N, Moore D. Overview and immunosuppression. In: Hasse JM, Blue LS, eds. Comprehensive Guide to Transplant Nutrition. Chicago, Ill: American Dietetic Association; 2002:1-30.
10. Jindal RM, Sidner RA, Milgrom ML. Post-transplant diabetes mellitus: the role of immunosuppression. Drug Safety. 1997;16: 242-257.
11. Heisel O, Heisel R, Balshaw R, et al. Meta-analysis of posttransplantation diabetes (PTDM) in patients receiving calcineurin inhibitors (CNI): ATC 2002. Am J Transplant. 2002; 2(suppl 3): Poster (SA-PO507).
12. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation. 2003;75:SS3-SS24.
13. Jindal RM, Hjelmesaeth J. Impact and management of posttransplant diabetes mellitus. Transplantation. 2000;70:SS58-SS62.
14. Jindal RM. Posttransplant diabetes mellitus: a review. Transplantation. 1994;58:1289-1298.
15. Benedini S, Fiocchi R, Battezzati A, et al. Energy metabolism in diabetic and nondiabetic heart transplant recipients. Diabetes Care. 2002;25:530-536.
16. White JR, Campbell RK. Pharmacologic therapies for glucose management. In: Funnell M, Hunt C, Kulkarni K, Rubin RR, Yarborough PC, eds. A Core Curriculum for Diabetes Education. 5th ed. Chicago, Ill: American Association of Diabetes Educators; 2003:115-132.
17. HHS News: Rezulin to be Withdrawn From the Market. US Department of Health and Human Services, Food and Drug Administration; 2000.
18. Kraus RM, Eckel RH, Howard B, et al. AHA dietary guidelines revision 2000: a statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation. 2000;102:2284-2299.
19. nd Scientific Sessions, abstract, June 16, 2002.
20. Obayashi PA, Simos A. Optimizing blood glucose prevents diabetes-related complications pre- and post-multi-organ transplantation [abstract]. J Am Diab Assoc. 2002;51(suppl 2):A214.
21. Delahanty L, Begay SR, Coocyate N, et al. The effectiveness of lifestyle intervention in the diabetes prevention program: application in diverse ethnic groups. Cutting Edge. 2002;23:30-35.